Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, implanted the Solo Smart surgical replacement performed by David Heimansohn, M.D., at St. Vincent’s Heart Hospital in Indianapolis, Ind.
Backus Hospital, Hartford Hospital, The Hospital of Central Connecticut, MidState Medical Center, and Windham Hospital now gather and analyze dose data from all necessary modalities within their imaging departments to ensure an effective dose management program for their patients through the use of Sectra DoseTrack.
This multi-center pilot study focused on gathering data supporting the safety and performance of the Tack Endovascular System in 35 subjects with Critical Limb Ischemia (CLI) due to vascular disease below the knee.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Cardinal Health announced that its MynxGrip Vascular Closure Device recently received U.S. Food and Drug Administration (FDA) approval for use to close femoral veins. The MynxGrip device is now indicated for use to seal 5F, 6F and 7F femoral arterial and femoral venous access sites.
Cardiovascular Systems Inc. received the CE Mark for its Stealth 360Âş Orbital Atherectomy System (OAS). Stealth 360Âş is a percutaneous OAS that is indicated to treat patients who suffer from peripheral arterial disease (PAD).
Calgary Scientific Inc. has announced a partnership with OnBase by Hyland to extend mobile image-access capability to its enterprise content management (ECM) platform. OnBase empowers superior care across the healthcare enterprise by making information readily available to clinicians and staff within the applications they already use and know, driving improvements in patient care and service while reducing operational costs.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
The Gammex “micro” diode laser family offers an economical alternative to conventional laser systems used for alignment purposes. Gammex “micro” has dimensions that are considerably smaller than other fixed lasers.
"Innovative fetal intervention may prove to be a game-changer in many cases, but it is too soon to declare its superiority over current conventional strategies for management of hypoplastic left heart syndrome," says Jack Rychik, M.D., director of the Fetal Heart Program at The Children's Hospital of Philadelphia (CHOP).
Future prevention and treatment strategies for vascular diseases may lie in the evaluation of early brain imaging tests long before heart attacks or strokes occur, according to a systematic review conducted by a team of cardiologists, neuroscientists, and psychiatrists from Icahn School of Medicine at Mount Sinai and published in the October issue of JACC Cardiovascular Imaging.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The Radiological Society of North America (RSNA) will officially kick off its 100th annual meeting and scientific assembly (Nov. 30 – Dec. 5, McCormick Place, Chicago) with a look back on the role RSNA has played in the history of radiology, brought to life in the RSNA Centennial Showcase.
Enrollment is open for the Dual Epicardial and Endocardial Procedure (DEEP) clinical trial following U.S Food and Drug Administration Approval (FDA).
Food and Drug Administration gave 510(k) clearance for the HawkOne directional atherectomy system. The latest addition to Covidien’s directional atherectomy portfolio, the HawkOne system provides physicians with an enhanced cutting mechanism to more effectively treat the widest variety of plaque in patients with peripheral arterial disease (PAD).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Shockwave Medical announced that the company will present clinical results from DISRUPT PAD, a single-arm multicenter study evaluating the safety and utility of Lithoplasty balloon catheters for the treatment of peripheral artery disease (PAD), at the Vascular Interventional Advances (VIVA) Annual Conference taking place Nov. 4-7 in Las Vegas.
Genetic predisposition to elevated low-density lipoprotein cholesterol (LDL-C) was associated with aortic valve calcium and narrowing of the aortic valve, findings that support a causal association between LDL-C and aortic valve disease, according to a study appearing in JAMA.
The U.S. Food and Drug Administration (FDA) has cleared the Abbott family of Xience everolimus-eluting coronary stents for the additional indication to treat coronary chronic total occlusions (CTOs).
November 07, 2014
